ARNA Stock Summary

• With a price/earnings ratio of 4.17, Arena Pharmaceuticals Inc P/E ratio is greater than that of about only 3.92% of stocks in our set with positive earnings.
• In terms of twelve month growth in earnings before interest and taxes, Arena Pharmaceuticals Inc is reporting a growth rate of -675.96%; that's higher than merely 2.04% of US stocks.
• As for revenue growth, note that ARNA's revenue has grown 5,728.92% over the past 12 months; that beats the revenue growth of 99.84% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Arena Pharmaceuticals Inc are SIGA, PULM, AEZS, SHIP, and RIGL.
• Visit ARNA's SEC page to see the company's official filings. To visit the company's web site, go to www.arenapharm.com.